The Precedent: Federal Circuit Provides Further Clarity on Issues Surrounding Patent Validity in Novartis Pharmaceuticals Corp. v. Torrent Pharma Inc.

In this edition of The Precedent, we outline the validity of a pharmaceutical patent concerning the patent’s written description. Following an appeal from the United States District Court for the District of Delaware, the Federal Circuit considered challenges to the validity of a pharmaceutical patent concerning the patent’s written description, enablement, and obviousness….
By: Vorys, Sater, Seymour and Pease LLP